Literature DB >> 10613754

Cholangiocarcinoma in primary sclerosing cholangitis: who is at risk and how do we screen?

P C de Groen.   

Abstract

Entities:  

Mesh:

Year:  2000        PMID: 10613754     DOI: 10.1002/hep.510310137

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  6 in total

Review 1.  Current therapies and clinical controversies in the management of primary sclerosing cholangitis.

Authors:  R T Prall; K D Lindor; R H Wiesner; N F LaRusso
Journal:  Curr Gastroenterol Rep       Date:  2000-04

2.  Hepatitis B virus infection: a favorable prognostic factor for intrahepatic cholangiocarcinoma after resection.

Authors:  Hua-Bang Zhou; Hui Wang; Yu-Qiong Li; Shuang-Xi Li; Hao Wang; Dong-Xun Zhou; Qian-Qian Tu; Qing Wang; Shan-Shan Zou; Meng-Chao Wu; He-Ping Hu
Journal:  World J Gastroenterol       Date:  2011-03-14       Impact factor: 5.742

3.  MUC1 and MUC5AC mucin expression in liver fluke-associated intrahepatic cholangiocarcinoma.

Authors:  Chanchai Boonla; Banchob Sripa; Peti Thuwajit; Ubon Cha-On; Anucha Puapairoj; Masanao Miwa; Sopit Wongkham
Journal:  World J Gastroenterol       Date:  2005-08-28       Impact factor: 5.742

Review 4.  Risk factors for gallbladder cancer and cholangiocarcinoma: similarities, differences and updates.

Authors:  Tarun Rustagi; Constantin A Dasanu
Journal:  J Gastrointest Cancer       Date:  2012-06

5.  Cholangiocarcinoma and high-grade dysplasia in young patients with primary sclerosing cholangitis.

Authors:  Roy Liu; Kristen Cox; Stephen L Guthery; Linda Book; Benjamin Witt; Barbara Chadwick; Douglas G Adler
Journal:  Dig Dis Sci       Date:  2014-04-19       Impact factor: 3.199

6.  Demographics, tumor characteristics, treatment, and survival of patients with Klatskin tumors.

Authors:  Prabin Sharma; Siddhartha Yadav
Journal:  Ann Gastroenterol       Date:  2018-02-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.